From: Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
Disease category | Number | Percent | PETmaj abnormal | # With coincident ADa | # mCERADSOT abnormal |
---|---|---|---|---|---|
Alzheimer's Diseasea | 66 | (62%) | 62 | 66 | 64 |
Lewy Body Diseaseb | 29 | (27%) | 23 | 16 | 22 |
Cerebral Amyloid Angiopathyc | 27 | (25%) | 23 | 24 | 25 |
Vasculard | 21 | (20%) | 14 | 14 | 16 |
Arteriosclerosise | 13 | (12%) | 9 | 9 | 11 |
Infarct | 7 | (7%) | 3 | 2 | 3 |
Normal | 6 | (6%) | 0 | 0 | 0 |
Ageing Changes | 3 | (3%) | 0 | 0 | 0 |
TDP43 immunopositivef | 3 | (3%) | 0 | 0 | 2 |
Tangle predominant dementia | 2 | (2%) | 0 | 0 | 0 |
Progressive Supranuclear Palsy | 2 | (2%) | 0 | 0 | 0 |
Atherosclerosis | 2 | (2%) | 1 | 2 | 2 |
Frontotemporal Dementia | 1 | (1%) | 0 | 0 | 0 |
Metastatic carcinoma | 1 | (1%) | 1 | 1 | 1 |
Hydrocephalus | 1 | (1%) | 1 | 1 | 1 |
Multiple system atrophy | 1 | (1%) | 1 | 0 | 1 |
Neurofibrillary degeneration | 1 | (1%) | 0 | 0 | 1 |
Parkinson's Disease | 1 | (1%) | 0 | 0 | 0 |